Related Experiment Video
Updated: Aug 1, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
COVID-19-associated familial acute disseminated encephalomyelitis (ADEM): A case report
Sivaram Neppala1, Dinesh Kumar Sundarakumar2, Joseph W Caravella1
1Department of Inte\rnal Medicine, University of Incarnate Word at Laredo Medical Center, Laredo, TX, 78041 USA.
Background:
Several neurological complications are being reported in hospitalized patients with severe COVID-19 infection. This is presumed due to direct spread of infection or due to immunological response. Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory and demyelinating disorder of the central nervous system that is often preceded by infection or vaccination. Very few cases of ADEM have been reported in the literature that are associated with COVID-19 infection.
Case Report:
Here we demonstrate familial cases of ADEM in a hospitalized father and son, who presented to the emergency department with fever and shortness of breath, later diagnosed with COVID-19, and subsequently requiring mechanical ventilation. Both patients developed neurological symptoms with upper motor neuron involvement at approximately day 30 of admission. MRI of the brain demonstrated bilateral multifocal periventricular white matter FLAIR signal hyperintensities consistent with ADEM. The patients were treated with medium dose IV methylprednisolone with variable outcomes. The 49-year-old son developed severe residual neurological deficits with encephalomalacic changes on MRI which required extensive rehabilitation; meanwhile, the 68-year-old father predominantly had pulmonary sequelae including fibrosis and the development of a pneumatocele, but he had a better neurological outcome.
Conclusion:
To our knowledge, this is the first reported case report of ADEM involving father and son in severe COVID-19 infection. Final neurological outcomes in these patients appeared to be in line with the severity of COVID-19 infection. More research is needed to better understand the management of ADEM in patients with severe COVID-19 infection.
Insights
This case report details a father and son with severe COVID-19 who developed Acute Disseminated Encephalomyelitis (ADEM). Their neurological outcomes varied, highlighting the unpredictable impact of COVID-19 on the central nervous system.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Severe COVID-19 infections can lead to neurological complications, potentially from direct viral invasion or immune responses.
- Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating CNS disorder typically following infection or vaccination.
- Few ADEM cases linked to COVID-19 have been documented.
Observation:
- A father and son hospitalized with severe COVID-19 presented with fever and respiratory distress.
- Both developed neurological symptoms, including upper motor neuron signs, approximately 30 days post-admission.
- Brain MRI revealed findings consistent with ADEM in both patients.
Findings:
- Familial ADEM associated with severe COVID-19 infection was observed in a father and son.
- Treatment with intravenous methylprednisolone yielded variable neurological outcomes.
- The son experienced significant neurological deficits and MRI changes, while the father had better neurological recovery despite pulmonary complications.
Implications:
- This is the first reported instance of ADEM in a father-son pair with severe COVID-19.
- Neurological outcomes in COVID-19-associated ADEM appear correlated with overall disease severity.
- Further research is crucial to optimize ADEM management in severe COVID-19 patients.
Related Concept Videos
Viral Meningitis
Poliomyelitis
Arboviral Encephalitis
Cryptococcal Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

